Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder

This study has been terminated.
(The investigator at Cedars stopped this study due to problems collecting payment from the sponsor.)
Sponsor:
Information provided by:
Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT00572377
First received: December 12, 2007
Last updated: June 19, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)